Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio's Approved Drugs Database

Xopenex

Levalbuterol Hydrochloride

Download PDF containing detailed information. PDF Version

Image Results

Press Releases About Xopenex:
MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Medical Affairs	23rd July, 2008	MAP Pharmaceuticals, Inc.	MOUNTAIN VIEW, Calif., July 23 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced the appointment of Donald J. Kellerman, Pharm.D. to the position of Senior Vice

Companies working in the area of Xopenex from Bioportfolio's Biocorporate database :
Company Name
Sepracor Sepracor Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease by discovering, developing, and commercializing innovative pharmaceutical products that are... www.sepracor.com View full profile

This page has been viewed 49 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Xopenex across BioPortfolio, or for Xopenex Research Reports

Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

BioPortfolio's Approved Drugs Database

Xopenex

Levalbuterol Hydrochloride

Image Results

Press Releases About Xopenex:

Companies working in the area of Xopenex from Bioportfolio's Biocorporate database :

Sepracor